BLCO$20.001.96%-0.40
Bausch Lomb Corp (BLCO)
Date: 2026-10-30 16:00O: 20.85H: 20.85L: 19.83C: 20.00Vol: 1.413M
Bausch Lomb Corp stock is traded at $20.00, with a volume of 1,412,760. It is down -1.96% in the last 24 hours and up +17.65% over the past month. Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
Previous Close:
$20.40
Open:
$20.85
24h Volume:
1,412,760
Relative Volume:
1.17
Market Cap:
$7.15B
Revenue:
$5.21B
Net Income/Loss:
-$211.00M
P/E Ratio:
-
EPS:
-$0.6179
Net Cash Flow:
$861.30K
1W Performance:
+14.48%
1M Performance:
+17.65%
6M Performance:
+25.79%
1Y Performance:
+32.10%
1-Day Range:
$19.83$20.85
1-Week Range:
$17.30$21.36
52-Week Range:
$14.44$21.36
Bausch Lomb Corp Stock (BLCO) Company Profile
Name
Bausch Lomb CorpSector
HealthcareIndustry
Medical Instruments & SuppliesPhone
908-541-5456Address
520 APPLEWOOD CRESCENT, VAUGHAN, CanadaCompare BLCO vs ISRG, BDX, ALC, RMD, WST
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BLCO Bausch Lomb Corp | $20.00 | $7.15B | $5.21B | -$211.00M | $861.30K | -$0.6179 |
 ISRG Intuitive Surgical Inc | $432.01 | $152.62B | $11.03B | $3.16B | $3.22B | $8.73 |
 BDX Becton Dickinson Co | $197.88 | $53.90B | $21.37B | $1.41B | $3.07B | $3.94 |
 ALC Alcon Inc | $71.45 | $34.54B | $10.63B | $819.00M | $1.59B | $1.66 |
 RMD Resmed Inc | $229.94 | $32.34B | $5.54B | $1.52B | $1.74B | $10.37 |
 WST West Pharmaceutical Services Inc | $412.62 | $28.79B | $3.22B | $542.70M | $458.00M | $7.48 |
Bausch Lomb Corp Stock (BLCO) Upgrades & Downgrades
Bausch Lomb Corp Stock (BLCO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Bausch Lomb Corp Stock (BLCO) Insider Trading
- Ling KarenSep 28 '26Former Director
- Transaction
- Proposed Sale
- Cost
- $16.83
- #Shares
- 4,500
- Value ($)
- 75,735
- #Shares Total
- 0
- Munsch FrederickAug 10 '26SVP, Controller and CAO
- Transaction
- Sale
- Cost
- $16.78
- #Shares
- 52,900
- Value ($)
- 887,662
- #Shares Total
- 45,831
- Munsch FrederickAug 10 '26Former Officer
- Transaction
- Proposed Sale
- Cost
- $16.78
- #Shares
- 52,900
- Value ($)
- 887,885
- #Shares Total
- 0
- VON ESCHENBACH ANDREW C.Aug 07 '26Former Director
- Transaction
- Proposed Sale
- Cost
- $16.58
- #Shares
- 6,059
- Value ($)
- 100,430
- #Shares Total
- 0
- VON ESCHENBACH ANDREW C.Aug 07 '26Director
- Transaction
- Sale
- Cost
- $16.58
- #Shares
- 6,059
- Value ($)
- 100,458
- #Shares Total
- 63,733
- VON ESCHENBACH ANDREW C.Aug 06 '26Director
- Transaction
- Sale
- Cost
- $16.50
- #Shares
- 12,500
- Value ($)
- 206,250
- #Shares Total
- 69,792
- VON ESCHENBACH ANDREW C.Aug 06 '26Former Director
- Transaction
- Proposed Sale
- Cost
- $16.50
- #Shares
- 12,500
- Value ($)
- 206,193
- #Shares Total
- 0
- SAUNDERS BRENT LMar 06 '26CEO and Chairman of the Board
- Transaction
- Buy
- Cost
- $17.14
- #Shares
- 14,700
- Value ($)
- 251,958
- #Shares Total
- 966,575
- Eldessouky SamMar 06 '26EVP and CFO
- Transaction
- Buy
- Cost
- $17.13
- #Shares
- 4,000
- Value ($)
- 68,520
- #Shares Total
- 403,130
- Bailey A Robert DMar 06 '26EVP & Chief Legal Officer
- Transaction
- Buy
- Cost
- $17.15
- #Shares
- 14,600
- Value ($)
- 250,332
- #Shares Total
- 231,890
